Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadopiclenol PK/Safety in Japanese Healthy Volunteers
NCT04906005Phase 1Completed
- Sponsor
- Guerbet
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Gadopiclenol with Placebo (2 arms). Primary endpoints: Maximum Plasma Concentration, Time to Maximum Concentration and 7 more. Started May 2021; status: completed.
02
Drugs
gadopiclenol
Beyond the preview
Go deeper on NCT04906005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04906005.